ANN ARBOR, Mich., Oct. 28 /PRNewswire-FirstCall/ -- Adeona Pharmaceuticals, Inc., (AMEX: AEN) announced today that the Company will hold its Annual Shareholders Meeting on Tuesday, November 2, from 9 a.m. to 10 a.m., at its offices located at 3930 Varsity Drive, Ann Arbor, MI, 48108.
During the Annual Shareholder Meeting, Adeona's Chief Executive Officer, James S. Kuo, M.D., M.B.A., will give an update on the Company's activities and answer questions. Admission is open to any Adeona shareholder of record as of September 23, 2010.
About Adeona Pharmaceuticals, Inc.
Adeona (AMEX: AEN) is a pharmaceutical company developing new medicines for serious central nervous systems diseases. Our primary strategy is to license clinical-stage drug candidates that have already demonstrated a certain level of clinical efficacy and develop them to a valuation inflection point resulting in a significant development and marketing collaboration. We have four drug candidates and one medical food candidate in development. Further information on the company is available at www.adeonapharma.com.